Edaravone Injection, Solution
Product Images NDC 68083-501

This text describes an Edaravone Injection for intravenous infusion. It is a sterile solution provided in single-dose bags that contain 30 mg of active edaravone. Inactive ingredients include L-cysteine hydrochloride hydrate, sodium bisulfite, sodium chloride for tonicity, and phosphoric acid and sodium hydroxide for pH adjustment to 4. The infusion is recommended to be administered over a 30-minute period. Each pack contains two 100 mL bags.*

This is a description of a medication called Edaravone Injection, intended for intravenous infusion. Each 100mL bag contains active ingredient 60g of Edaravone. It is a sterile solution in single-dose form, with instructions to discard any unused portion. The infusion is recommended to be done over 60 minutes. Inactive ingredients include L-cysteine hydrochloride hydrate, sodium bisulfite, and additives for isotonicity and pH adjustment. This medication is available by prescription only.*

This is a product information sheet for Edaravone Injection, which is intended for intravenous infusion. Each single-dose bag contains 30 mg of edaravone along with other inactive ingredients. The dosage and administration instructions recommend infusing each 30 mg/100 ml bag over a 30-minute period. Cautions include keeping the solution away from children, not swallowing it, and discarding unused portions. Once opened, the solution should be used within 24 hours and should not be mixed with other drugs. Storage guidelines suggest storing the product between 20 to 25 degrees Celsius. The product is manufactured by Gland Pharma Limited in Hyderabad, India.*

This is a description of Edaravone Injection, containing 60 mg of active edaravone per 100 mL bag. It is intended for intravenous infusion and must be discarded if unused. The medication contains inactive ingredients such as L-cystine hydrochloride hydrate and sodium bisulfite. Dosage instructions recommend infusing 2 bags over a period of 60 minutes. Caution is advised to keep out of reach of children, not to swallow, and not to mix with other drugs. Once the packaging is opened, it should be used within 24 hours. Storage instructions include keeping it between 20° to 25°C.*

The text appears to be a detailed description of a pharmaceutical product, specifically Edaravone Injection. It includes information such as the concentration of the medication, single-dose packaging, ingredients, dosage instructions, cautions, usage guidelines, storage recommendations, and details about the manufacturer. The product is presented in a 100 mL single-dose pack with 30 mg of Edaravone. It is important to follow the dosage instructions and storage conditions provided for this medication.*